Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 30Gastrointestinal 18Genitourinary 13Thoracic 7Other hematologic neoplasm 5Lymphoid 5Head & Neck 5Dermatologic 2Sarcoma 1Plasma cell 1Gynecologic 1Endocrine 1CNS 1

Conditions

Multiple Endocrine Neoplasia Type 1 96Pituitary Neoplasms 57Neuroendocrine Tumors 50Thyroid Cancer, Papillary 42Thyroid Neoplasms 16Obesity 15Pheochromocytoma 14Overweight 11Adrenal Gland Neoplasms 10Weight Loss 9Paraganglioma 9Carcinoma, Neuroendocrine 9Pancreatic Neoplasms 8Prostatic Neoplasms 7Motor Activity 7Insulinoma 7Gastrointestinal Neoplasms 7Brain Neoplasms 7Adrenocortical Adenoma 7Acquired Immunodeficiency Syndrome 7Neoplasm Metastasis 6Hyperaldosteronism 6Carcinoma, Medullary 6Stomach Neoplasms 5Osteoporosis 5Neoplasms 5Meningioma 5Liver Neoplasms 5Insulin Resistance 5HIV Infections 5

Interventions

parecoxib 1loxoprofen 1Tramadol 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Agnosia × Endocrine × Clear all
NCT04611685 2020-11-03

Pain Management After Transnasal Transsphenoidal Surgery for Pituitary Adenomas

Peking Union Medical College Hospital

Phase NA Unknown
202 enrolled
Endocrine

Agnosia, Pain, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡